MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Nutrition, Motor And Non-Motor Symptoms Impact On Life’s Quality In Parkinson’s Disease In Second-Line Therapies

N. Ayo Mentxakatorre, M. Acera Gil, C. Juanes, B. Tijero, M. Ruiz-Lopez, T. Fernandez-Valle, J. Gomez-Esteban, R. Del Pino (Barakaldo, Spain)

Meeting: 2025 International Congress

Keywords: Deep brain stimulation (DBS), Non-motor Scales, Parkinson’s

Category: Parkinson's Disease (Other)

Objective: Analyze the nutritional status, motor and non-motor symptoms of patients with Parkinson´s disease (PD) with second-line therapies [levodopa carbidopa intestinal gel (LCIG) and deep brain stimulation (DBS)] and their impact on the quality of life (QoL).

Background: PD is a neurodegenerative disorder characterized by progressive dopamine loss. While levodopa controls motor symptoms, long-term use leads to fluctuations and dyskinesias. Second-line therapies like LCIG and DBS help manage these complications. LCIG stabilizes motor symptoms but may affect nutrient absorption, whereas DBS improves motor function and can cause weight gain. Managing these factors could influence patients’ QoL.

Method: We studied 55 PD patients treated with LCIG (n=25) or DBS (n=30). The Nutritional status was evaluated with the MNA, Vitamin B6-B12, and albumin; motor function with UPDRS I-IV and non-motor symptoms with NMSS; cognition with MoCA; and QoL with PDQ-39. The analyses performed were one-way ANOVA, Tukey Post-Hoc, and Spearman correlation.

Results: Statistically significant differences were found: DBS group got better results than the LCIG group in nutritional status (albumin;p˂.001), motor (UPDRSI;p˂.001, UPDRSIII;p˂.039) and non-motor symptoms (NMSS;p˂.011), cognition (MoCA;p˂.027), and QoL (PDQ-39;p˂.001). In the LCIG group, 8.3% were malnourished, 45.8% were at risk of malnutrition, and 45.8% had a normal nutritional status. In the DBS group, 6.7% were malnourished, 16.7% were at risk of malnutrition, and 76.6% had a normal nutritional status. The correlation analysis showed a better nutritional status, in both groups, were related to a better motor function (UPDRS II: Rho=.504,p˂.001; III: Rho=.346,p=.025; IV: Rho=.348, p=.026), non-motor symptoms (Rho=.297,p=.005), and QoL(Rho=.427,p˂.001); the QoL decreased with disease duration (Rho=-.249,p=.021) and was related to better scores in motor symptoms (UPDRS II: Rho=.516,p˂.001; III: Rho=.447,p=.003), cognition (Rho=.306,p˂.005), and in nutritional status (Rho=.427,p˂.001).

Conclusion: Our results revealed that a better nutritional status was associated with better motor and non-motor performance, impacting PD patients’ QoL. The DBS group obtained better results than the LCIG group. In PD patients with second-line therapies, better nutritional status was associated with better performance on motor and non-motor symptoms, ultimately impacting QoL.

References: Femat-Roldán G, Gaitán Palau MA, Castilla-Cortázar I, Elizondo Ochoa G, Moreno NG, Martín-Estal I, et al. Altered Body Composition and Increased Resting Metabolic Rate Associated with the Postural Instability/Gait Difficulty Parkinson’s Disease Subtype. Parkinsons Dis 2020;2020:1–9. https://doi.org/10.1155/2020/8060259.
Jiménez CT, Sánchez VS, de Damas Medina M, Irigoyen CA, Ramírez MJM. Nutrición en la enfermedad de Parkinson. Nutrición Clínica 2017;11:96–113. https://doi.org/10.7400/NCM.2017.11.2.5052.
Miguel Francisco Sepúlveda-Contardo, Joaquín Emilio Gay-San Martín, Diego Nicolás Vásquez-Peña, Pilar Valeria Obreque-Faundez, Karen Camila Roa-Bustos MFS-G. Impacto de los trastornos motores del habla y deglución sobre la calidad de vida de personas con enfermedad de Parkinson: una revisión sistemática de la literatura. Rev Ecuat Neurol 2023;32. https://doi.org/10.46997/revecuatneurol32100055.
Fernandez RD, Bezerra GMB, Krejcová LV, Gomes DL. Correlations between Nutritional Status and Quality of Life of People with Parkinson’s Disease. Nutrients 2023;15:3272. https://doi.org/10.3390/nu15143272.
Batisse-Lignier M, Rieu I, Guillet C, Pujos E, Morio B, Lemaire J-J, et al. Deep Brain Stimulation of the Subthalamic Nucleus Regulates Postabsorptive Glucose Metabolism in Patients With Parkinson’s Disease. J Clin Endocrinol Metab 2013;98:E1050–4. https://doi.org/10.1210/jc.2012-3838.
Montaurier C, Morio B, Bannier S, Derost P, Arnaud P, Brandolini-Bunlon M, et al. Mechanisms of body weight gain in patients with Parkinson’s disease after subthalamic stimulation. Brain 2007;130:1808–18. https://doi.org/10.1093/brain/awm113.

To cite this abstract in AMA style:

N. Ayo Mentxakatorre, M. Acera Gil, C. Juanes, B. Tijero, M. Ruiz-Lopez, T. Fernandez-Valle, J. Gomez-Esteban, R. Del Pino. Nutrition, Motor And Non-Motor Symptoms Impact On Life’s Quality In Parkinson’s Disease In Second-Line Therapies [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/nutrition-motor-and-non-motor-symptoms-impact-on-lifes-quality-in-parkinsons-disease-in-second-line-therapies/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/nutrition-motor-and-non-motor-symptoms-impact-on-lifes-quality-in-parkinsons-disease-in-second-line-therapies/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley